Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Beth

Allianz turns to insurtech to offer wary travelers instant claims

Allianz’s partnership with Blink, an insurtech start-up that offers quick and automatic pay-outs and re-bookings through its digital app, will allow the insurer to modernize its travel insurance offering and win consumers over once the heavily-disrupted travel industry is up and running again, says GlobalData, a leading data and analytics company. GlobalData’s 2020 UK Insurance […]
Read more

COVID-19 and sustainability will be key insurance themes in 2021

COVID-19 will be by far and away the most important theme in insurance throughout 2021, but sustainability will continue to be an essential long-term theme, according to GlobalData, a leading data and analytics company. GlobalData’s latest thematic report, ‘Insurance Predictions 2021 – Thematic Research’, states that COVID-19 will be the defining theme until 2023, as […]
Read more

Consumer discretionary sector drives S&P 500 index performance

Consumer discretionary stocks led the S&P 500 charge between 31 January 2020 and 31 January 2021, while energy stocks remained the worst performing sector, according to analysis by GlobalData, a leading data and analytics company. Aggregate market cap of S&P 500 index constituents grew 18% from $28.4 trillion to $33.5 trillion over the period, and the index posted an annual return of 15.2% – whereas the return was […]
Read more

Mitsubishi Motors rightly seeing new opportunity in Europe

Following reports that Mitsubishi Motors is considering a reversal of its decision to pull back from Europe and have its cars made at a Renault plant in France; David Leggett, Automotive Analyst at GlobalData, a leading data and analytics company, offers his view: “The pandemic is resetting automakers’ strategic compasses in many ways and creating […]
Read more

Diagnosed prevalent cases of HIV to reach 2.1 million by 2029 in the 7MM

The diagnosed prevalent cases of human immunodeficiency virus (HIV) in the seven major markets (7MM*) are projected to increase from 1.87 million in 2019 to 2.1 million in 2029, with an annual growth rate (AGR) of 1.06%, according to GlobalData, a leading data and analytics company. The company’s latest report, ‘Human Immunodeficiency Virus (HIV): Epidemiology […]
Read more

SARS-CoV-2 mutations could make COVID-19 endemic

The recent SARS-CoV-2 virus variant in South Africa (B.1.351) underscores a critical weakness in combatting the COVID-19 epidemic and may prolong it indefinitely, says GlobalData, a leading data and analytics company. South Africa made headlines when it announced that it would be suspending AstraZeneca’s COVID-19 vaccine (AZD1222). The vaccine’s efficacy was below 25% in South […]
Read more

IATA’s digital Covid Travel Pass could spark meaningful recovery of international travel

Following an announcement from the International Air Transport Association (IATA), stating that its digital Covid Travel Pass will be ready “within weeks”; Ralph Hollister, Analyst, Travel & Tourism at GlobalData, a leading data and analytics company, offers his view on the situation: “IATA’s Travel Pass is not the golden ticket to an instant recovery for the global travel sector, but it will no doubt help. According to GlobalData, international air arrivals decreased by 48.1% YOY (Year-Over-Year) […]
Read more

Over 2,800 AI start-ups received funding from more than 3,700 VC investors during 2020

Among all the technology themes, artificial intelligence (AI) attracted the largest number of investors during 2020, while blockchain and cybersecurity led in terms of investors-to-idea ratio (number of venture capital (VC) investors / number of funded companies) and average deal size, respectively, according to GlobalData, a leading and data analytics company. Over 2,800 AI start-ups […]
Read more

Success in Parkinson’s disease development pipeline relies on Roche’s prasinezumab overcoming recent string of failures

The Parkinson’s disease (PD) pipeline has been hit significantly with a string of failures among its most anticipated mid-stage pipeline candidates. This news presents a challenge for similar disease-modifying therapies (DMTs) undergoing development such as Roche’s prasinezumab. It also amplifies that a major unmet need remains in bringing DMTs and neuroprotective agents to this market, […]
Read more

Sales of injectable anti-HIV therapeutics will reach US$2bn in 2029

The human immunodeficiency virus (HIV) therapeutics market was worth an estimated $22.9bn across the seven major markets (7MM*) in 2019. The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 2%, reaching $28bn in 2029, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘HIV Therapeutics: Global Drug Forecast and Market Analysis to 2029’, reveals that growth in the market will be driven by […]
Read more

Semiconductor shortages to impact auto industry recovery in 2021

GlobalData forecasts the global light vehicle market at 85.1 million units in 2021, 13.1% ahead of 2020’s pandemic-hit total. However, the year will be a tumultuous one for auto sales, with major market swings and considerable uncertainties ahead, according to Globaldata, a leading data and analytics company. Calum MacRae, Automotive Analyst at GlobalData, comments: “In […]
Read more

US dominates upcoming oil and gas project starts in North America by 2025

The US will drive upcoming project starts across the oil and gas value chain in North America, accounting for 70% of the total projects expected to start operations by 2025. Of these, new build projects dominate with 83%, while the remaining are expansion projects mainly in the upstream sector (fields, excluding shale), according to GlobalData, a leading data, and analytics company. GlobalData’s report, ‘North America Oil and Gas Projects Outlook to 2025 – Development Stage, Capacity, Capex and Contractor Details of All New Build and Expansion Projects’, reveals that 417 projects […]
Read more
1 … 39 40 41 42 43 … 93